Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...

Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...

According to Dealroom, in Q1 2025, European startups have secured $15.8B through nearly 1,600 funding rounds. From AI and fintech to clean energy and biotech, startups have attracted large amounts of ...

As STAT’s Katie Palmer reports in a new story, the lack of standards for collection of this information will make it more ...

Isomorphic Labs, which broke off from Google's DeepMind in 2021, raised $600 million from investors in a new funding round ...

Isomorphic Labs CEO Demis Hassabis discusses $600M funding round, plans for a US office, and expanding into ...

Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...

在科技飞速发展的今天，药物研发已进入了一个全新的时代。尤其在人工智能 (AI)的帮助下，各种药物的诞生与设计变得更加高效与精准。你是否已经听说过Isomorphic Labs？当我们谈论下一代的制药技术时，这家公司就像是一道闪亮的光辉，吸引了众多目光！就在本周一，Isomorphic Labs宣布成功融资6亿美元，不禁让我们对这波资金注入感到惊讶与期待！

在科技飞速发展的当下，制药行业也在迎来一场颠覆性的变革。近日，位于英国的Isomorphic Labs像一颗璀璨的新星，吸引了全世界的目光。这个被誉为“魔法实验室”的公司，宣布成功融资6亿美元，目标是加快其人工智能技术的研发和应用，实现药物开发的重大突破。

The companies Isomorphic Labs, DBV Technologies, and Genfit bagged the biggest biotech funding rounds overall in March 2025.

UK-based AI-first development company Isomorphic Labs revealed that it has raised $600 Million in its first external funding round. The financing round is led by Thrive Capital, with participation ...

Though Isomorphic is burning through millions in R&D costs now, investors have high hopes for the potential of AI drug ...